Method, compositions, and compounds for modulating brain excitab

Details Method, compositions, and compounds for modulating brain excitab Method, compositions, and compounds for modulating brain excitab

1990-05-10

1992-06-09

Shen, Cecilia

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514177, 514178, 514179, 514180, 514181, 514182, 540 89, 540 94, 540 95, 540 97, 540 99, 540106, 540107, 540108, 540109, 540110, 540111, 540112, 540113, 540114, 540118, 540119, 540120, 548146, 548201, A61K 3156, A61K 3144, A61K 31425, A61K 31445, A61K 3158, A61K 31495, A61K 31465, C07J 4100

Patent

active

051207230

ABSTRACT:
Method, compositions, and compounds for modulating brain excitability to alleviate stress, anxiety, and seizure activity using certain steroid derivatives that act at a newly identified site on the gamma-ammobutyric acid/benzodiazepine receptor-chloride ionpore (GBR) complex.

REFERENCES:
patent: 4213978 (1980-07-01), Bodor et al.
Majewska, M. D. et al, Science, 232:1004-1007 (1986).
Harrison, N. L. et al, J. Pharmacol. Exp. Ther. 241:346-353 (1987).
Backstrom, T. et al. Acta Obstet. Gynecol. Scand. Suppl. 130:19-24 (1985).
Pfaff, D. W. et al. Science, 219:808-814 (1983).
Gyermek, et al, J. Med. Chem. 11:117 (1968).
Laidlaw, Lancet, 1235-1237 (1956).
Marker, R. E. et al, J.A.C.S. 59, 616-618 (1937).
Bordor, Drugs of the Future, 6(3):165-182 (1981).
Gee, et al, European Journal of Pharmacology 136:419-423 (1987).
Morrian et al, Biochem, 40:376-380 (1947).
Lawrence, L. J. et al, Biochem. Biophys. Res. Comm. 123:1130-1137 (1984).
Backstrom, T. et al., Acta Endocr. Supp., 256:257, 1983.
Bodor, J. Pharmaceutical Sciences, 73(3):385-389, 1984.
Dalton, K., The Premenstrual Syndrome and Progesterone Therapy, 2nd edition, 1984.
Dennerstein et al., British Medical Journal, 290:1617-1621, 1985.
Gee, K. W. et al., in Drugs In Central Nervous System Disorders, pp. 123-147, D. C. Horvell, ed., 1985.
Gee, K. W., et al., Molecular Pharmacology, 30:218-225, 1986.
Maddocks, S., et al., Obstet. Gynecol., 154:573-581, 1986.
Maksay, G. et al., J. Neurochem., 44:480-486, 1985.
Mattson, R. H., et al., in Advances in epileptology: XVth Epilepsy International Symposium, Raven Press, New York, 279-282, 1984.
Notari, R. E., Methods in Enzymology, 112:309-323 (1985).
Rosciszewska, D., et al., J. Neurol. Neurosurg. Psych., 49:47-51, 1986.
Squires, R. F. et al., Mol. Pharmacol., 23:326-336, 1983.
Swinyard, E. A., et al., in Antiepileptic Drugs, D. M. Woodbury, J. K. Penry and C. E. Pippenger, eds., p. 111 (Raven Press, New York) 1982.
Wood, P. L., et al., J. Pharmacol. Exp. Ther., 231:572-576, 1984.
Worms, P. L. et al., J. Pharmacol. Exp. Ther., 220;660-671, 1982.

Affiliated with

Also associated with

Rating

Method, compositions, and compounds for modulating brain excitab does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method, compositions, and compounds for modulating brain excitab, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method, compositions, and compounds for modulating brain excitab will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1804598